DTL
CHRS icon

Dynamic Technology Lab’s Coherus Oncology CHRS Stock Holding History

Dynamic Technology Lab’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,556
Closed -$34K – 1046
2024
Q2 		$34K Buy
+19,556
New +$39.4K ﹤0.01% 891
2024
Q1 		– Sell
-24,261
Closed -$81K – 1078
2023
Q4 		$81K Buy
+24,261
New +$65K 0.01% 953
2023
Q3 		– Sell
-15,694
Closed -$67K – 992
2023
Q2 		$67K Sell
15,694
-26,719
-63% -$158K 0.01% 922
2023
Q1 		$290K Buy
+42,413
New +$329K 0.03% 806
2022
Q4 		– Sell
-20,500
Closed -$197K – 1148
2022
Q3 		$197K Sell
20,500
-21,989
-52% -$223K 0.02% 964
2022
Q2 		$308K Buy
+42,489
New +$369K 0.03% 757
2022
Q1 		– Sell
-24,483
Closed -$391K – 1144
2021
Q4 		$391K Buy
+24,483
New +$428K 0.04% 702
2021
Q2 		– Sell
-39,924
Closed -$583K – 1174
2021
Q1 		$583K Buy
+39,924
New +$678K 0.07% 492
2020
Q2 		– Sell
-31,586
Closed -$512K – 1002
2020
Q1 		$512K Buy
31,586
+8,852
+39% +$164K 0.1% 351
2019
Q4 		$409K Buy
22,734
+5,606
+33% +$103K 0.07% 541
2019
Q3 		$347K Buy
+17,128
New +$342K 0.06% 590
2019
Q2 		– Sell
-21,630
Closed -$295K – 992
2019
Q1 		$295K Buy
21,630
+7,876
+57% +$105K 0.05% 675
2018
Q4 		$125K Sell
13,754
-21,589
-61% -$250K 0.02% 880
2018
Q3 		$583K Buy
35,343
+21,538
+156% +$382K 0.08% 442
2018
Q2 		$193K Buy
+13,805
New +$198K 0.03% 861

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dynamic Technology Lab's CHRS Position: Q3 2024 in Review

Dynamic Technology Lab sold out of Coherus Oncology (CHRS) in Q3 2024, closing a stake of 19,556 shares — an estimated $34K sold.

Dynamic Technology Lab first reported a position in CHRS in Q2 2018 and held it in 15 quarters. The position peaked at $583K in Q1 2021. 128 funds tracked by Wall St. Rank hold CHRS as of Q3 2024.

  • Dynamic Technology Lab reported no remaining Coherus Oncology position as of Q3 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 19,556 Coherus Oncology shares in Q3 2024, an estimated $34K.
  • Dynamic Technology Lab first reported a position in Coherus Oncology in Q2 2018 and held it in 15 quarters.
  • Dynamic Technology Lab's Coherus Oncology position peaked at $583K in Q1 2021.
  • 128 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2024.

Based on Dynamic Technology Lab's 13F filing for Q3 2024, filed 13 Nov 2024.